Sun Pharma to buyout local partner in Mexican arm
The company has signed a binding letter of intent to acquire the balance 25 per cent outstanding shares of Sun Pharma de Mexico, SA de CV, a subsidiary where it currently holds 75 per cent shares, Sun Pharmaceutical Industries said in a regulatory filing.
)
Sun Pharmaceutical Industries Ltd on Thursday said it will buy out local partner Indi Pharma from its Mexican arm for MXN 161.85 million (over Rs 75 crore).
The company has signed a binding letter of intent to acquire the balance 25 per cent outstanding shares of Sun Pharma de Mexico, SA de CV, a subsidiary where it currently holds 75 per cent shares, Sun Pharmaceutical Industries said in a regulatory filing.
The balance of 25 per cent is held by local partner Indi Pharma S.A.P.I. De CV, it added.The cost of acquisition is MXN 161.85 million, it added.
TRENDING NOW
"The acquisition enables Sun Pharma to acquire the balance 25 per cent stake held by the local partner," the company said, adding it would be done through a wholly-owned subsidiary Sun Pharma (Netherlands) B.V.
The acquisition is likely to be completed by October 31, 2023, and after that, Sun Pharma de Mexico SA de CV will become a wholly-owned subsidiary of the company, it said.
Sun Pharma de Mexico is engaged in the marketing and distribution of pharmaceutical products in Mexico.
07:01 pm
Sun Pharma inks licensing pact with Aclaris Therapeutics
D-Street Newsmakers: L&T, Sun Pharma, JSPL and MRPL among 10 stocks that buzzed the most today
Sun Pharma Q2 net up 5% at Rs 2,375 crore
Zydus, Sun Pharma ink licensing pact to co-market CKD treatment drug